scholarly journals Spinal Cord Stimulation and Pain Relief in Painful Diabetic Peripheral Neuropathy: A Prospective Two-Center Randomized Controlled Trial

Diabetes Care ◽  
2014 ◽  
Vol 37 (11) ◽  
pp. 3016-3024 ◽  
Author(s):  
Rachel Slangen ◽  
Nicolaas C. Schaper ◽  
Catharina G. Faber ◽  
Elbert A. Joosten ◽  
Carmen D. Dirksen ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Randomized Controlled Trial ◽  
Peripheral Neuropathy ◽  
Pain Relief ◽  
Spinal Cord Stimulation ◽  
Diabetic Peripheral Neuropathy ◽  
Controlled Trial ◽  
Randomized Controlled ◽  
Painful Diabetic Peripheral Neuropathy

A Real-World Analysis of High-Frequency 10 kHz Spinal Cord Stimulation for the Treatment of Painful Diabetic Peripheral Neuropathy

2021 ◽  
pp. 193229682110603
Author(s):  
Jeffrey L. Chen ◽  
Andrew W. Hesseltine ◽  
Sara E. Nashi ◽  
Shawn M. Sills ◽  
Tory L. McJunkin ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Peripheral Neuropathy ◽  
Pain Relief ◽  
Diabetic Neuropathy ◽  
Real World ◽  
Spinal Cord Stimulation ◽  
Diabetic Peripheral Neuropathy ◽  
High Frequency ◽  
Clinical Practices ◽  
Painful Diabetic Peripheral Neuropathy

Background: Diabetes is one of the most prevalent chronic health conditions and diabetic neuropathy one of its most prevalent and debilitating complications. While there are treatments available for painful diabetic peripheral neuropathy (pDPN), their effectiveness is limited. Method: This retrospective, multi-center, real-world review assessed pain relief and functional improvements for consecutive patients with diabetic neuropathy aged ≥18 years of age who were permanently implanted with a high-frequency (10 kHz) spinal cord stimulation (SCS) device. Available data were extracted from a commercial database. Results: In total 89 patients consented to being included in the analysis. Sixty-one percent (54/89) of participants were male and the average age was 64.4 years (SD = 9.1). Most patients (78.7%, 70/89) identified pain primarily in their feet or legs bilaterally. At the last assessment, 79.5% (58/73) of patients were treatment responders, defined as having at least 50% patient-reported pain relief from baseline. The average time of follow-up was 21.8 months (range: 4.3 to 46.3 months). A majority of patients reported improvements in sleep and overall function relative to their baseline. Conclusions: This real-world study in typical clinical practices found 10 kHz SCS provided meaningful pain relief for a substantial proportion of patients refractory to current pDPN management, similar to published literature. This patient population has tremendous unmet needs and this study helps demonstrate the potential for 10 kHz SCS to provide an alternative pain management approach.

16-LB: Long-Term 10 kHz Spinal Cord Stimulation in Painful Diabetic Neuropathy: A Randomized Controlled Trial

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 16-LB
Author(s):  
ERIKA PETERSEN ◽  
JAMES SCOWCROFT ◽  
ELIZABETH S. BROOKS ◽  
JUDITH L. WHITE ◽  
KASRA AMIRDELFAN ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Randomized Controlled Trial ◽  
Diabetic Neuropathy ◽  
Spinal Cord Stimulation ◽  
Controlled Trial ◽  
Painful Diabetic Neuropathy ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document